Review Article
Nano-Oncology: Clinical Application for Cancer Therapy and Future Perspectives
Table 2
Examples of liposomes available on the market and in clinical use.
| | Composition | Trade name | Company | Indication | Administration |
| | Liposomal daunorubicin | DaunoXome | Gilead Sciences | Kaposi’s sarcoma | intravenous |
| | Stealth liposomal doxorubicin | Doxil/Caelyx | Ortho Biotech, Schering-Plough | Kaposi’s Sarcoma; refractory ovarian cancer; refractory breast cancer | intramuscular |
| | Liposomal doxorubicin | Myocet | Zeneus | Metastatic breast cancer in combination with cylophosphamide | intravenous |
| | Liposomal muramyl Tripeptide phosphatidyl Ethanolamine | MEPACT | Taked | Osteosarcoma | intravenous |
| | Cytarabine | Depocyt | SkyePharma PLC | Lymphomatous meningitis | intrathecal |
| | Liposomal vincristine | Onco-TCS | Inex Enzon | Non-hodgking lymphoma | intravenous |
|
|
